These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15729851)

  • 1. Descriptors you can count on? Normalized and filtered pharmacophore descriptors for virtual screening.
    Good AC; Cho SJ; Mason JS
    J Comput Aided Mol Des; 2004; 18(7-9):523-7. PubMed ID: 15729851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oriented substituent pharmacophore PRopErtY space (OSPPREYS): a substituent-based calculation that describes combinatorial library products better than the corresponding product-based calculation.
    Martin EJ; Hoeffel TJ
    J Mol Graph Model; 2000; 18(4-5):383-403. PubMed ID: 11143557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-D pharmacophores in drug discovery.
    Mason JS; Good AC; Martin EJ
    Curr Pharm Des; 2001 May; 7(7):567-97. PubMed ID: 11375769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the descriptor pharmacophores using variable selection QSAR: applications to database mining.
    Tropsha A; Zheng W
    Curr Pharm Des; 2001 May; 7(7):599-612. PubMed ID: 11375770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simple idea to generate fragment and pharmacophore descriptors and their implications in chemical informatics.
    Catana C
    J Chem Inf Model; 2009 Mar; 49(3):543-8. PubMed ID: 19243168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating the extension of pairwise distance pharmacophore measures to triplet-based descriptors.
    Good AC; Kuntz ID
    J Comput Aided Mol Des; 1995 Aug; 9(4):373-9. PubMed ID: 8523046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flexophore, a new versatile 3D pharmacophore descriptor that considers molecular flexibility.
    von Korff M; Freyss J; Sander T
    J Chem Inf Model; 2008 Apr; 48(4):797-810. PubMed ID: 18393490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How diverse are diversity assessment methods? A comparative analysis and benchmarking of molecular descriptor space.
    Koutsoukas A; Paricharak S; Galloway WR; Spring DR; Ijzerman AP; Glen RC; Marcus D; Bender A
    J Chem Inf Model; 2014 Jan; 54(1):230-42. PubMed ID: 24289493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fuzzy tricentric pharmacophore fingerprints. 1. Topological fuzzy pharmacophore triplets and adapted molecular similarity scoring schemes.
    Bonachéra F; Parent B; Barbosa F; Froloff N; Horvath D
    J Chem Inf Model; 2006; 46(6):2457-77. PubMed ID: 17125187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a chirality-sensitive flexibility descriptor for 3+3D-QSAR.
    Dervarics M; Otvös F; Martinek TA
    J Chem Inf Model; 2006; 46(3):1431-8. PubMed ID: 16711763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New 4-point pharmacophore method for molecular similarity and diversity applications: overview of the method and applications, including a novel approach to the design of combinatorial libraries containing privileged substructures.
    Mason JS; Morize I; Menard PR; Cheney DL; Hulme C; Labaudiniere RF
    J Med Chem; 1999 Aug; 42(17):3251-64. PubMed ID: 10464012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining pharmacophore fingerprints and PLS-discriminant analysis for virtual screening and SAR elucidation.
    Askjaer S; Langgård M
    J Chem Inf Model; 2008 Mar; 48(3):476-88. PubMed ID: 18281962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring CAMD technique performance: a virtual screening case study in the design of validation experiments.
    Good AC; Hermsmeier MA; Hindle SA
    J Comput Aided Mol Des; 2004; 18(7-9):529-36. PubMed ID: 15729852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the structural requirements in diverse scaffolds for the inhibition of P. falciparum dihydroorotate dehydrogenase (PfDHODH) using 2D-QSAR, 3D-pharmacophore and structure-based energy- optimized pharmacophore models.
    Aher RB; Roy K
    Comb Chem High Throughput Screen; 2015; 18(2):217-26. PubMed ID: 25543684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parallel screening: a novel concept in pharmacophore modeling and virtual screening.
    Steindl TM; Schuster D; Laggner C; Langer T
    J Chem Inf Model; 2006; 46(5):2146-57. PubMed ID: 16995745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Library design using BCUT chemistry-space descriptors and multiple four-point pharmacophore fingerprints: simultaneous optimization and structure-based diversity.
    Mason JS; Beno BR
    J Mol Graph Model; 2000; 18(4-5):438-51, 538. PubMed ID: 11143561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A self-organizing algorithm for molecular alignment and pharmacophore development.
    Bandyopadhyay D; Agrafiotis DK
    J Comput Chem; 2008 Apr; 29(6):965-82. PubMed ID: 17999384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parameterization and conformational sampling effects in pharmacophore multiplet searching.
    Fox PC; Wolohan PR; Abrahamian E; Clark RD
    J Chem Inf Model; 2008 Dec; 48(12):2326-34. PubMed ID: 19053520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational sampling of druglike molecules with MOE and catalyst: implications for pharmacophore modeling and virtual screening.
    Chen IJ; Foloppe N
    J Chem Inf Model; 2008 Sep; 48(9):1773-91. PubMed ID: 18763758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of ligand- and structure-based virtual screening on the DUD data set.
    von Korff M; Freyss J; Sander T
    J Chem Inf Model; 2009 Feb; 49(2):209-31. PubMed ID: 19434824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.